Meningitis B vaccine rejected
A vaccine that protects against a potentially deadly form of meningitis should not be offered to children in the UK, immunisation experts have said.
Meningitis B vaccine 'unlikely to be cost-effective'
There is "insufficient" evidence available to support the introduction a Meningitis B immunisation, Government-appointed experts have said.
The Joint Committee on Vaccination and Immunisation (JCVI) said the efficacy of the Bexsero vaccine "has not been established" and it is "high unlikely" to be cost-effective.
The vaccine was licensed by the European Medicines Agency at the start of the year.
More top news
-
Joe Biden vows to fight racial inequality with economic agenda
The Democratic presidential candidate may also have shown his cards on his choice of running mate.
-
Trump reverts to promoting unproven drug as coronavirus treatment
The US president also shared a post on Twitter accusing Dr Anthony Fauci of misleading the public over hydroxychloroquine.
-
What the papers say – July 29
Fears over an impending second wave of coronavirus dominates Wednesday’s front pages.